Logo image
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis—Coordinating Research Priorities to Move the Field Forward
Journal article   Peer reviewed

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis—Coordinating Research Priorities to Move the Field Forward

E.J. Phillips, C.S. Bouchard and S.J. Divito
JAMA Dermatology, Vol.158(6), pp.607-608
2022
url
Link to Published Version *Subscription may be requiredView

Abstract

Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) is the most life-threatening disease managed by dermatologists. Although SJS/TEN only affects 1 to 5 million people per year, mortality remains stable at 15%, and to our knowledge, high-level evidence-based treatment options are lacking. The SJS/TEN meeting1,2 that was held virtually August 28 and 29, 2021, brought together multidisciplinary clinicians, scientists, and community members to share knowledge, research, stories, and support. In this Viewpoint, we provide our perspective of the successes and gaps in research and clinical care of SJS/TEN that were highlighted at this meeting and propose future opportunities for prioritization and optimization.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.265 Dermatology - Skin Allergies
1.265.1140 Drug Hypersensitivity
Web Of Science research areas
Dermatology
ESI research areas
Clinical Medicine
Logo image